Bayer Loses Roundup Appeal -- Update
July 20 2020 - 4:48PM
Dow Jones News
By Sara Randazzo
Bayer AG lost an appeal in the first case to go to trial linking
its Roundup weedkiller to cancer, though the California court
greatly reduced the amount of damages awarded to $20.4 million.
The Monday decision by the California Court of Appeal comes in
the case of school groundskeeper Dewayne Johnson, who won a 2018
jury trial blaming Roundup for causing his non-Hodgkin lymphoma.
The jury's initial $289.2 million award sent Bayer's stock tumbling
and was followed by an even larger $2 billion award in a second
trial.
Bayer, which inherited Roundup's legal liabilities with its $63
billion acquisition of seed and pesticide maker Monsanto Co. two
years ago, recently said it would pay up to $10.9 billion to settle
tens of thousands of Roundup lawsuits. The company said at the time
it was still pursuing appeals in the three cases that have gone to
trial.
Bayer has steadfastly said that Roundup and the weedkiller's
active ingredient, glyphosate, are safe and backed by regulators
including the U.S. Environmental Protection Agency. The company had
argued to the California court that the jury decision should be
thrown out in part because it conflicts with an EPA position
preventing the company from putting a cancer-warning label on the
product.
The court disagreed, finding that while the EPA currently says
glyphosate isn't harmful to humans and that no cancer warning is
needed, "that opinion, in the abstract, isn't binding on this
court."
In shutting down separate arguments Bayer had made, the
three-judge panel also said, "In our view, Johnson presented
abundant -- and certainly substantial -- evidence that glyphosate,
together with the other ingredients in Roundup products, caused his
cancer." The judges pointed to experts who told jurors that Roundup
could cause non-Hodgkin lymphoma generally as well as Mr. Johnson's
cancer in particular.
The court reduced damages for economic loss to $10.2 million and
said any punitive damage should match, granting total damages of
$20.4 million. The judge who oversaw the trial had already reduced
the original award to $78.5 million.
Brent Wisner, an attorney for Mr. Johnson, called the Monday
ruling "another major victory" for Mr. Johnson and his family. He
said the reduction in damages is "a function of a deep flaw in
California tort law" that makes it difficult to have money awarded
for a shortened lifespan, an issue he hopes would be addressed if
the case goes to the California Supreme Court.
Bayer can still appeal the case to California's highest court.
The company didn't immediately respond to requests for comment
Monday.
Glyphosate's safety came under scrutiny in 2015 after the
International Agency for Research on Cancer, a unit of the World
Health Organization, classified glyphosate as likely having the
potential to cause cancer.
Write to Sara Randazzo at sara.randazzo@wsj.com
(END) Dow Jones Newswires
July 20, 2020 16:33 ET (20:33 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Sep 2023 to Sep 2024